Le Lézard
Classified in: Health, Science and technology
Subjects: TRI, FDA

BioProtect receives FDA's clearance for its biodegradable balloon for rectal protection during prostate cancer radiation therapy


TZUR YIGAL, Israel, Aug. 28, 2023 /PRNewswire/ -- Israeli medical devices manufacturer BioProtect Ltd. announced today that their BioProtect Balloon Implanttm System has been cleared by the FDA. The biodegradable balloon is a new generation spacer designed to provide optimal, consistent, and reproducible protection to the rectum during prostate cancer radiation therapy.

According to the American Cancer Society, prostate cancer is the second most common cancer among men in the United States, with 288,300 new cases diagnosed in 2023.

"We believe that our balloon has the potential to revolutionize rectal protection from toxicity during prostate cancer radiation therapy," said Itay Barnea, CEO of BioProtect. "Not only does it provide better protection to healthy organs, it also supports dose escalation and hypofractionation, which are leading trends in prostate cancer radiation therapy."

"The BioProtect Balloon offers me the opportunity to optimize treatment for almost all men with prostate cancer, even those with high-risk disease. The fact that it provides additional space with a pre-formed contour, the ability to adjust its position, and high visibility with all imaging modalities would make it the choice for my patients," says Edward Soffen, MD, of Princeton Radiation Oncology.

BioProtect is based in Israel and is backed by Triventures, Almeda ventures, KB investment, Peregrine Ventures, Consensus Business Group of Vincent Tchenguiz and other leading VCs. To drive the company's penetration into the US market, the company has announced the appointment of Ken Knudson as General Manager and Chief Commercial Officer. Knudson, who will lead BioProtect's activity in the US, has a proven commercial track record in Urology and medical devices in general, including prior positions at Bard, Augmenix and Boston Scientific.

For more information about BioProtect and their products, please visit www.BioProtect.com.

Images can be downloaded here.

SOURCE BioProtect


These press releases may also interest you

at 09:52
Jumo Health?a global provider of age-appropriate, culturally relevant medical education?today announced that Kevin Aniskovich, the Company's President and CEO, will be moderating a roundtable discussion, "Why Authenticity and the Patient Voice is...

at 09:45
BEDGEAR®, renowned in the sleep industry for pushing boundaries to offer innovative sleep solutions for humans who aspire to Wake Readytm, is proud to announce the launch of its new and highly sought after Storm King Performance® Pillow. After...

at 09:44
BSV Blockchain today announced the release of its new SPV (Simplified Payment Verification) Wallet, which is now available in public beta, following a private beta period. The SPV Wallet, developed and maintained by the BSV Association, is an...

at 09:31
In recent appearances at high-profile events in Paris and Dubai, Vivien Lin, the Chief Product Officer at BingX, a leading platform in the cryptocurrency exchange and financial services sector, emphasized the company's user-centric approach as...

at 09:30
PlanHub, the premier cloud software platform for commercial construction professionals, will have a featured presence at Advancing Preconstruction 2024, taking place from May 1st -3rd in Denver, CO. They will host an exclusive breakfast networking...

at 09:30
Mega Broadband Investments LLC ("MBI"), a leading provider of broadband services across the Southeast, Northwest, and Mid-South United States that goes to market under the Vyve Broadband brand ("Vyve"), today announced that Andy Parrott has been...



News published on and distributed by: